tiprankstipranks
Trending News
More News >
Beam Therapeutics (BEAM)
NASDAQ:BEAM
US Market

Beam Therapeutics (BEAM) Cash flow

Compare
2,086 Followers

Beam Therapeutics Cash Flow

BEAM's free cash flow for Q3 2025 was $-86.49M. For the 2025 fiscal year, BEAM's free cash flow was decreased by $-173.26M and operating cash flow was $-81.48M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -347.25M$ -149.19M$ 22.53M$ -66.27M$ -95.74M
Investing Cash Flow
$ 185.01M$ 71.84M$ -461.34M$ -294.14M$ -100.12M
Financing Cash Flow
$ 7.74M$ 276.45M$ 111.59M$ 756.14M$ 322.32M
End Cash Position
$ 290.11M$ 444.61M$ 245.52M$ 572.74M$ 177.01M
Free Cash Flow
$ -356.19M$ -182.93M$ -26.42M$ -113.08M$ -112.10M
Currency in USD

Beam Therapeutics Cash Flow